Toward a genome-based treatment landscape for renal cell carcinoma

Francesco Massari, Vincenzo Di Nunno, Matteo Santoni, L. Gatto, Claudia Caserta, Franco Morelli, E. Zafarana, Francesco Carrozza, Alessandra Mosca, Veronica Mollica, Roberto Iacovelli, Roberto Sabbatini, Camillo Porta, Sergio Bracarda

Research output: Contribution to journalReview article


Knowledge about molecular mechanisms driving development and progression of renal cell carcinoma has been elucidated by different studies. In few years we discovered a large difference between genomic landscapes of clear cell and non-clear cell carcinoma. Moreover, tumor heterogeneity and different acquisition of gene mutations during tumor progression are issues of particular interest. In this review we focalized our attention on principal genomic alterations identified among RCC subtypes. Acquired gene mutations may be an adaptive response to several external pressure including metabolic, treatment, genomic and immune-related external pressure. Thus we correlated and discussed principal genomic alterations adopted by tumor to escape from each external pressures. The aim of the present work is to summarize current knowledge about genomic alterations in RCC with special interest of treatment strategies tailored on the basis of disease mutations assessment.

Original languageEnglish
Pages (from-to)141-152
Number of pages12
JournalCritical Reviews in Oncology/Hematology
Publication statusPublished - Oct 1 2019


  • Chromophobe RCC
  • Clear cell RCC
  • Genomic landscape
  • Genomic mutations
  • Oncocytoma
  • Papillary RCC
  • RCC

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Toward a genome-based treatment landscape for renal cell carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Massari, F., Di Nunno, V., Santoni, M., Gatto, L., Caserta, C., Morelli, F., Zafarana, E., Carrozza, F., Mosca, A., Mollica, V., Iacovelli, R., Sabbatini, R., Porta, C., & Bracarda, S. (2019). Toward a genome-based treatment landscape for renal cell carcinoma. Critical Reviews in Oncology/Hematology, 142, 141-152.